Cargando…

Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis

Polarisation-sensitive optical coherence tomography (PS-OCT) offers a novel, non-invasive method of assessing skin fibrosis in the multisystem disease systemic sclerosis (SSc) by measuring collagen retardance. This study aimed to assess retardance as a biomarker in SSc. Thirty-one patients with SSc...

Descripción completa

Detalles Bibliográficos
Autores principales: Marjanovic, E. J., Sharma, V., Smith, L., Pinder, C., Moore, T. L., Manning, J. B., Dinsdale, G., Berks, M., Newton, V. L., Wilkinson, S., Dickinson, M. R., Herrick, A. L., Watson, R. E. B., Murray, A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861061/
https://www.ncbi.nlm.nih.gov/pubmed/35190594
http://dx.doi.org/10.1038/s41598-022-06783-7
_version_ 1784654804352499712
author Marjanovic, E. J.
Sharma, V.
Smith, L.
Pinder, C.
Moore, T. L.
Manning, J. B.
Dinsdale, G.
Berks, M.
Newton, V. L.
Wilkinson, S.
Dickinson, M. R.
Herrick, A. L.
Watson, R. E. B.
Murray, A. K.
author_facet Marjanovic, E. J.
Sharma, V.
Smith, L.
Pinder, C.
Moore, T. L.
Manning, J. B.
Dinsdale, G.
Berks, M.
Newton, V. L.
Wilkinson, S.
Dickinson, M. R.
Herrick, A. L.
Watson, R. E. B.
Murray, A. K.
author_sort Marjanovic, E. J.
collection PubMed
description Polarisation-sensitive optical coherence tomography (PS-OCT) offers a novel, non-invasive method of assessing skin fibrosis in the multisystem disease systemic sclerosis (SSc) by measuring collagen retardance. This study aimed to assess retardance as a biomarker in SSc. Thirty-one patients with SSc and 27 healthy controls (HC) underwent PS-OCT imaging. ‘Skin score’ was assessed by clinical palpation (0–3 scale). A subset of ten patients and ten age/sex-matched HC had a biopsy and longitudinal imaging. Histological assessment included quantification of epidermal thickness, collagen content (to assess fibrosis) and matrix metalloproteinase (MMP) activity (in situ zymography). PS-OCT images were assessed for epidermal thickness (structure) and fibrosis (retardance). Positive correlation was observed between epidermal thickness as measured by histology and structural PS-OCT (r = 0.79; p < 0.001). Retardance was: HC mean 0.21 (SD 0.21) radian/pixel; SSc skin score 0, 0.30 (0.19); skin score 1, 0.11 (0.16); skin score 2, 0.06 (0.12); skin score 3, 0.36 (0.35). Longitudinal retardance decreased at one-week across groups, increasing at one-month for HC/skin score 0–1; HC biopsy site retardance suggests scarring is akin to fibrosis. Relationships identified between retardance with both biopsy and skin score data indicate that retardance warrants further investigation as a suitable biomarker for SSc-related fibrosis.
format Online
Article
Text
id pubmed-8861061
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88610612022-02-22 Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis Marjanovic, E. J. Sharma, V. Smith, L. Pinder, C. Moore, T. L. Manning, J. B. Dinsdale, G. Berks, M. Newton, V. L. Wilkinson, S. Dickinson, M. R. Herrick, A. L. Watson, R. E. B. Murray, A. K. Sci Rep Article Polarisation-sensitive optical coherence tomography (PS-OCT) offers a novel, non-invasive method of assessing skin fibrosis in the multisystem disease systemic sclerosis (SSc) by measuring collagen retardance. This study aimed to assess retardance as a biomarker in SSc. Thirty-one patients with SSc and 27 healthy controls (HC) underwent PS-OCT imaging. ‘Skin score’ was assessed by clinical palpation (0–3 scale). A subset of ten patients and ten age/sex-matched HC had a biopsy and longitudinal imaging. Histological assessment included quantification of epidermal thickness, collagen content (to assess fibrosis) and matrix metalloproteinase (MMP) activity (in situ zymography). PS-OCT images were assessed for epidermal thickness (structure) and fibrosis (retardance). Positive correlation was observed between epidermal thickness as measured by histology and structural PS-OCT (r = 0.79; p < 0.001). Retardance was: HC mean 0.21 (SD 0.21) radian/pixel; SSc skin score 0, 0.30 (0.19); skin score 1, 0.11 (0.16); skin score 2, 0.06 (0.12); skin score 3, 0.36 (0.35). Longitudinal retardance decreased at one-week across groups, increasing at one-month for HC/skin score 0–1; HC biopsy site retardance suggests scarring is akin to fibrosis. Relationships identified between retardance with both biopsy and skin score data indicate that retardance warrants further investigation as a suitable biomarker for SSc-related fibrosis. Nature Publishing Group UK 2022-02-21 /pmc/articles/PMC8861061/ /pubmed/35190594 http://dx.doi.org/10.1038/s41598-022-06783-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Marjanovic, E. J.
Sharma, V.
Smith, L.
Pinder, C.
Moore, T. L.
Manning, J. B.
Dinsdale, G.
Berks, M.
Newton, V. L.
Wilkinson, S.
Dickinson, M. R.
Herrick, A. L.
Watson, R. E. B.
Murray, A. K.
Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
title Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
title_full Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
title_fullStr Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
title_full_unstemmed Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
title_short Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
title_sort polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861061/
https://www.ncbi.nlm.nih.gov/pubmed/35190594
http://dx.doi.org/10.1038/s41598-022-06783-7
work_keys_str_mv AT marjanovicej polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT sharmav polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT smithl polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT pinderc polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT mooretl polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT manningjb polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT dinsdaleg polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT berksm polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT newtonvl polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT wilkinsons polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT dickinsonmr polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT herrickal polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT watsonreb polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis
AT murrayak polarisationsensitiveopticalcoherencetomographymeasurementofretardanceinfibrosisanoninvasivebiomarkerinpatientswithsystemicsclerosis